The agreement grants Sinopharm exclusive rights to distribute the MUSE system in China.
With the agreement renewal, Sinopharm has been granted up to two years to gain all necessary regulatory approval and two to four years exclusivity rights following regulatory approvals.
As a part of the agreement, Sinopharm will purchase a minimum of $17.6 million of MUSE and related projects within four years of regulatory approval.
More articles on gastroenterology:
Dr. Anton Decker to serve as Mercy Health Physicians’ president
Are gastroenterologists looking for new avenues to increase practice revenue? 10 statistics
5 gastroenterologists leading GI mega-practices
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.